LAS VEGAS — Marvel Studios used one of the biggest stages in the exhibition calendar to pull back the curtain on its next ensemble film, closing its CinemaCon 2026 presentation with the first extended look at Avengers: Doomsday.

The studio’s president, Kevin Feige, appeared on stage alongside directors Anthony Russo and Joe Russo, signalling the scale of the project before the footage began. The moment took a sharper turn when Robert Downey Jr. walked out to the Rolling Stones’ “Sympathy For the Devil,” underscoring a casting reveal that is now central to the film’s identity.

Downey Jr., long associated with the role of Tony Stark, is set to play Doctor Doom, positioning the character as the primary antagonist. The footage shown to attendees suggested a darker tone, with a visibly strained Marvel Cinematic Universe and multiple factions converging.

Among those glimpsed were returning Avengers, Wakandan figures, members of the Fantastic Four, and characters drawn from the earlier Fox-era X-Men films. The studio also confirmed the return of Chris Evans as Steve Rogers, a development that had circulated informally but was presented here without ambiguity.

The film is directed by the Russo brothers and written by Michael Waldron and Stephen McFeely. It is produced by Marvel Studios in collaboration with AGBO and will be distributed by Walt Disney Studios Motion Pictures.

Scheduled for release on December 18, 2026, Avengers: Doomsday will mark the 39th entry in the MCU and forms part of its Phase Six slate. A follow-up, Avengers: Secret Wars, is already dated for December 17, 2027.

What stood out in the CinemaCon presentation was not just the scale of the crossover but the sense of a franchise attempting to recalibrate its stakes. The footage, by design, offered no full narrative outline, but it leaned heavily on the idea of convergence—of characters, timelines, and unresolved arcs.

For exhibitors in the room, the closing segment carried weight. After a presentation cycle that often balances spectacle with caution, Marvel chose a direct approach, anchoring its next phase around familiar faces in unfamiliar roles.